Patient info Open main menu

Metoclopramide Hydrochloride 10 mg tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
10 mg
Contains active substance:
Similar medicines:

Patient leaflet - Metoclopramide Hydrochloride 10 mg tablets

1. What Metoclopramide

Hydrochloride tablets is and what it is used for

Metoclopramide Hydrochlride is an antiemetic. It contains a medicine called “metoclopramide”. It works on a part of your brain that prevents you from feeling sick (nausea) or being sick (vomiting).

Adult population:

Metoclopramide Hydrochloride is used in adults: • to prevent delayed nausea and vomiting that may occur after chemotherapy

  • to prevent nausea and vomiting caused by radiotherapy
  • to treat nausea and vomiting including nausea and vomiting which may occur with a migraine. Metoclopramide can be taken with oral painkillers in case of migraine to help painkillers work more effectively.

Paediatric population

Metoclopramide Hydrochloride is indicated in children (aged 1-18 years) if other treatment does not work or cannot be used to prevent delayed nausea and vomiting that may occur after chemotherapy.

2. What you need to know before you take Metoclopramide Hydrochloride tablets

Do not take Metoclopramide Hydrochloride tablets:

  • if you are allergic to metoclopramide or any of the other ingredients of this medicine (listed in section 6) • if you have bleeding, obstruction or a tear in your stomach or gut.
  • if you have or may have a rare tumour of the adrenal gland, which sits near the kidney

    (pheochromocytoma).

  • if you have ever had involuntary muscle spasms (tardive dyskinesia), when you have been treated with a medicine.
  • if you have epilepsy
  • if you have Parkinson’s disease
  • if you are taking levodopa (a medicine for Parkinson’s disease) or dopaminergic agonists (see below “Other medicines and Metoclopramide Hydrochloride tablets”)
  • if you have ever had an abnormal blood pigment levels (methaemoglobinemia) or NADH

    cytochrome-b5 deficiency

Do not give Metoclopramide Hydrochloride tablets to a child less than 1 year of age (see below “Children and adolescents”).

Do not take Metoclopramide Hydrochloride tablets if any of the above applies to you. If you are not sure, talk to your doctor, pharmacist or nurse before taking Metoclopramide Hydrochloride tablets.

Warnings and precautions

Talk to your doctor, pharmacist or nurse before taking Metoclopramide Hydrochloride tablets if:

  • you have a history of abnormal heart beats (QT interval prolongation) or any other heart problems • you have problems with the levels of salts in your blood, such as potassium, sodium and magnesium. • you are using other medicines known to affect the way your heart beats
  • you have any neurological (brain) problems • you have liver or kidney problems. The dose may be reduced (see section 3).

Your doctor may perform blood tests to check your blood pigment levels. In cases of

abnormal levels (methaemoglobinemia), the treatment should be immediately and

permanently stopped.

You must wait at least 6 hours between each metoclopramide dose, even in case of

vomiting and rejection of the dose, in order to avoid overdose.

Do not exceed 3 months of treatment due to the risk of involuntary muscle spasm.

Children and adolescents

Uncontrollable movements (extrapyramidal disorders) may occur in children and young adults.

This medicine must not be used in children below 1 year of age because of the increased risk of the uncontrollable movements (see above “Do not take Metoclopramide Hydrochloride tablets if”).

Other medicines and Metoclopramide Hydrochloride tablets

Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any

other medicines. This is because some medicines can affect the way Metoclopramide

Hydrochloride tablets works or Metoclopramide Hydrochloride tablets can affect

how other medicines work. These medicines include the following:

  • levodopa or other medicines used to treat Parkinson’s disease (see above “Do not take Metoclopramide Hydrochloride tablets if”)

    • anticholinergics (medicines used to relieve stomach cramps or spasms)
    • morphine derivatives (medicines used to treat severe pain)
    • sedative medicines
    • any medicines used to treat mental health problems - digoxin (medicine used to treat heart failure) - cyclosporine (medicine used to treat certain problems with the immune system)
    • mivacurium and suxamethonium (medicines used to relax muscles)
    • fluoxetine and paroxetine (medicine used to treat depression)
    • rifampicin (a medicine used to treat tuberculosis or other infections), can reduce the amount of metoclopramide in the blood if it is given at the same time.

Metoclopramide Hydrochloride tablets with alcohol

Alcohol should not be consumed during treatment with metoclopramide because it

increases the sedative effect of Metoclopramide Hydrochloride tablets.

Pregnancy, breast-feeding and fertility

If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before being given this medicine. If necessary, Metoclopramide Hydrochloride tablets may be taken during pregnancy. Your doctor will decide whether or not you should be given this medicine.

Metoclopramide Hydrochloride tablets is not recommended if you are breast-feeding because metoclopramide passes into breast milk and may affect your baby.

Driving and using machines

You may feel drowsy, dizzy or have uncontrollable twitching, jerking or writhing movements and unusual muscle tone causing distortion of the body after taking Metoclopramide Hydrochloride tablets. This may affect your vision and also interfere with your ability to drive and use machines.

Metoclopramide Hydrochloride tablets contains Lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

3. How to take Metoclopramide Hydrochloride tablets

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Adult population:

The recommended single dose is 10 mg, repeated up to three times daily.

The maximum recommended dose per day is 30 mg or 0.5 mg/kg body weight.

The maximum recommended treatment

duration is 5 days.

To prevent delayed nausea and vomiting that may occur after chemotherapy

(children aged 1-18 years)

The recommended dose is 0.1 to 0.15

mg/kg body weight, repeated up to 3 times daily, taken by Mouth.

The maximum dose in 24 hours is 0.5 mg/kg body weight.

Dosing table

Age Body Weight Dose Frequency 1-3 years 10-14 kg 1 mg Up to

3 times daily

3-5 years 15-19 kg 2 mg Up to

3 times

daily

5-9 years 20-29 kg 2.5 mg Up to

3 times

daily

9-18 years 30-60 kg 5 mg Up to

3 times daily 15-18 years Over 60kg 10 mg Up to

3 times daily

Device / instruction for use

You should not take this medicine for more than 5 days to prevent delayed nausea and vomiting that may occur after chemotherapy.

Metoclopramide Hydrochloride tablets is not suitable for use in children weighing less than 30 kg. Other pharmaceutical forms/strengths may be more appropriate for administration

Method of administration

Swallow the tablet with glass of water.

You must wait at least 6 hours between each metoclopramide dose, even in case of vomiting and rejection of the dose, in order to avoid overdose.

Older people

The dose may need to be reduced depending on kidney problems, liver problems and overall health.

Adults with kidney problems

Talk to your doctor if you have kidney problems. The dose should be reduced if you have moderate or severe kidney problems.

Adults with liver problems

Talk to your doctor if you have liver problems. The dose should be reduced if you have severe liver problems.

Children and adolescents

Metoclopramide must not be used in children aged less than 1 year (see section 2).

If you take more Metoclopramide Hydrochloride tablets than you should

Contact your doctor or pharmacist straight away. You may experience uncontrollable movements (extrapyramidal disorders), feel drowsy, have some troubles of consciousness, be confused, have hallucination and heart problems. You doctor may prescribe you a treatment for these signs if necessary. PACKAGE LEAFLET: INFORMATION FOR THE USER

Metoclopramide Hydrochloride 10 mg tablets

(Metoclopramide Hydrochloride)

Front Side

-
CustomerAccord
DescriptionMetoclopramide
MarketUK
LanguageEnglish
170 x 550 mm (PIL)
9
Version No.6 (Page 1 of 2)
Date03~01~2024 (Metoclopramide (ACC-UK)SEZ-PIL)

(735073) Date : 23~05~2024, 01~06~2024, 03~06~2024, 04~06~2024, 13~06~2024, 18~06~2024, 17~07~2024

If you forget to take Metoclopramide Hydrochloride tablets

Do not take a double dose to make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.

4. Possible side effects

Like all medicines, Metoclopramide Hydrochloride tablets can cause side effects, although not everybody gets them.

Stop the treatment and talk straight away to your doctor or pharmacist if you experience one of the following side effects while using this medicine: - uncontrollable movements (often involving head or neck). These may occur in children or young adults and particularly when high doses are used. These reactions usually occur at the beginning of treatment and may even occur after one single administration. These movements will stop when treated appropriately. - high fever, high blood pressure, fits/seizures (convulsions), sweating, production of saliva. These may be signs of a condition called neuroleptic malignant syndrome.

  • Itching or skin rashes, swelling of the face, lips, throat or tongue, difficulty in breathing, shortness of breath, cold, clammy skin, rapid heartbeat, dizziness, weakness or fainting. These may be signs of an allergic reaction (such as anaphylaxis, angioedema and urticaria), which may be serious.

Very common (may affect more than 1 in 10 people) • feeling drowsy.

Common (may affect up to 1 in 10 people) • melancholy (depression)

  • uncontrollable movements such as tics, shaking, jerking movements or muscle contracture (stiffness, rigidity)
  • symptoms similar to those of Parkinson disease (rigidity, tremor)
  • feel restless
  • blood pressure decrease (particularly with intravenous route)
  • diarrhoea
  • feeling weak.

Uncommon (may affect up to 1 in 100 people) • raised levels of a hormone called prolactin in the blood which may cause milk production in men, and in women who are not breast-feeding

  • irregular periods
  • hallucination
  • decreased level of consciousness
  • slow heartbeat (particularly with intravenous route) • allergy
  • Visual disturbances (sight problems) and involuntary deviation of the eyeball

Rare (may affect up to 1 in 1,000 people) • confusional state

  • fits/seizures (convulsions) (especially in patients with epilepsy).

Not known (frequency cannot be estimated from the available data)

  • abnormal blood pigment levels: which may change

    the colour of your skin

    • abnormal development of breasts (gynaecomastia)
    • involuntary muscle spasms after prolonged use, particularly in elderly patients
    • high fever, high blood pressure, fits/seizures (convulsions), sweating, production of saliva. These may be signs of a condition called neuroleptic malignant syndrome • changes in heart beat, which may be shown on an ECG test
  • cardiac arrest (particularly with injection route) • shock (severe decrease in heart pressure) (particularly with injection route)
  • fainting (particularly with intravenous route) • very high blood pressure in patients with or without pheochromocytoma
  • suicidal thoughts

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Metoclopramide Hydrochloride tablets

Keep this medicine out of the sight and reach of children. • Store below 30 °C.

  • Do not use this medicine after the expiry date which is stated on the strips and carton after ‘EXP’. The expiry date refers to the last day of that month. • Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Metoclopramide Hydrochloride tablets contains

The name of your medicine is Metoclopramide Hydrochloride tablets, and the active substance is metoclopramide hydrochloride.

Metoclopramide Hydrochloride tablets contain 10 mg metoclopramide hydrochloride.

The tablets contain the following non-active ingredients: Lactose monohydrate, pre-gelatinised starch, maize starch, anhydrous colloidal silica, magnesium stearate.

What Metoclopramide Hydrochloride tablets looks like and contents of the pack

White to off-white, round, biconvex tablets with the inscription ‘BD’ on one side and a score line on the other side.

The tablet can be divided into equal halves. The tablets are packaged in PVC/PVdC/aluminium blister strips.

The carton contains 20, 24, 28, 30, 40, 50, 60, 84, 100, 500 tablets.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Accord Healthcare Limited,

Sage House, 319 Pinner Road, North Harrow, Middlesex HA1 4HF,

United Kingdom

Manufacturer

Accord Healthcare Polska Sp.z o.o., ul. Lutomierska 50,95-200 Pabianice, Poland

This leaflet was last revised in 05/2024.

Back Side

INP113 51 7298 0 735073

-
CustomerAccord
DescriptionMetoclopramide
MarketUK
LanguageEnglish
170 x 550 mm (PIL)
9
Version No.6 (Page 2 of 2)
Date03~01~2024 (Metoclopramide (ACC-UK)SEZ-PIL)

(735073) Date : 23~05~2024, 01~06~2024, 03~06~2024, 04~06~2024, 13~06~2024, 18~06~2024, 17~07~2024

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 20075/0331

Last revision stated in the text: May 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Metoclopramide Hydrochloride 10 mg tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Metoclopramide
Strength 10 mg
Pharmaceutical form Oral tablet
White to off-white, round, biconvex tablets with the inscription ‘BD’ on one side and a scoreline on the other side.
The tablet can be divided into equal halves.
How is it taken Oral
Excipients Lactose monohydrate., Pre-gelatinised starch., Maize starch., Anhydrous colloidal silica., Magnesium stearate.
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life The shelf life is 2 years in PVC/PVdC/aluminium blister strips.
Storage Store below 30 °C.
Drug group (ATC)
  1. A Alimentary tract and metabolism drugs
    1. A03 Drugs for functional gastrointestinal disorders
      1. A03F Propulsives
        1. A03FA Propulsives
          1. A03FA01 metoclopramide
Marketing authorisation PL 20075/0331 (first authorised 1 March 2012)
Marketing authorisation holder Accord Healthcare Limited
Codes GTIN 5012617009180 · BNF 04060000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.